Guzmán Alonso
Impact in
-
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cancer-related Molecular Pathways
- Pancreatic and Hepatic Oncology Research
-
- Cancer Genomics and Diagnostics
Papers in
- Oncology 22
- Cancer Immunotherapy and Biomarkers 8
- Lung Cancer Research Studies 5
- Colorectal Cancer Treatments and Studies 4
- CAR-T cell therapy research 4
-
- Lung Cancer Treatments and Mutations 12
- Co-authors
- Vivek Subbiah (7 shared papers)Benjamin Solomon (4 shared papers)Victoria Soldatenkova (4 shared papers)Oliver Gautschi (4 shared papers)Filippo de Braud (4 shared papers)Benjamin Besse (3 shared papers)Alexander Drilon (3 shared papers)Jürgen Wolf (1 shared paper)
- Journals
- Journal of Clinical Oncology (20 papers)Annals of Oncology (7 papers)Health Promotion International (1 paper)Future Oncology (1 paper)Expert Opinion on Investigational Drugs (1 paper)
- Partner nations
- SpainUnited StatesGermany
In The Last Decade
Guzmán Alonso
29 papers receiving 306 citations
Hit Papers
Peers
Comparison fields: 5 of 48
- Oncology 177
- Cancer Research 75
- Pulmonary and Respiratory Medicine 161
- Endocrinology, Diabetes and Metabolism 38
- Immunology 43
Countries citing papers authored by Guzmán Alonso
This map shows the geographic impact of Guzmán Alonso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guzmán Alonso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guzmán Alonso more than expected).
Fields of papers citing papers by Guzmán Alonso
This network shows the impact of papers produced by Guzmán Alonso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guzmán Alonso. The network helps show where Guzmán Alonso may publish in the future.
Co-authors
The 25 scholars most cited alongside Guzmán Alonso, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Selpercatinib in Patients With RET Fusion–Positive Non–Small-Cell Lung Cancer: Updated Safety and Efficacy From the Registrational LIBRETTO-001 Phase I/II Trial Hit paper breakdown → | 2022 | 119 |
| 2 | 2020 | 44 | |
| 3 | 2021 | 29 | |
| 4 | 2023 | 15 | |
| 5 | 2022 | 14 | |
| 6 | 2023 | 10 | |
| 7 | 2021 | 10 | |
| 8 | 2023 | 7 | |
| 9 | 2023 | 7 | |
| 10 | 2021 | 7 | |
| 11 | 2007 | 6 | |
| 12 | 2024 | 5 | |
| 13 | 2022 | 5 | |
| 14 | 2022 | 5 | |
| 15 | 2020 | 4 | |
| 16 | 2021 | 4 | |
| 17 | 2022 | 4 | |
| 18 | 2009 | 3 | |
| 19 | 2024 | 2 | |
| 20 | 2024 | 2 |
About Guzmán Alonso
Guzmán Alonso is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Immunology and Cancer Research, having authored 34 papers that have together received 313 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (12 papers), Cancer Immunotherapy and Biomarkers (8 papers), Cancer Genomics and Diagnostics (6 papers), Lung Cancer Research Studies (5 papers), Colorectal Cancer Treatments and Studies (4 papers), CAR-T cell therapy research (4 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Oncology (177 citations), Cancer Research (75 citations), Pulmonary and Respiratory Medicine (161 citations), Endocrinology, Diabetes and Metabolism (38 citations) and Immunology (43 citations). Guzmán Alonso has collaborated with scholars based in Spain, United States and Germany. Frequent co-authors include Vivek Subbiah, Benjamin Solomon, Victoria Soldatenkova, Oliver Gautschi, Filippo de Braud, Benjamin Besse, Alexander Drilon, Jürgen Wolf, Aimee Bence Lin and Keunchil Park. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Health Promotion International, Future Oncology and Expert Opinion on Investigational Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.